Joy Yan - Mar 1, 2022 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
Director
Signature
/s/ Jonathan Foster by Power of Attorney
Stock symbol
MBRX
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 08:48 PM
Previous filing
Dec 17, 2021
Next filing
May 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock Option (right to buy) Award +6.67K 6.67K Mar 1, 2022 Common Stock 6.67K $1.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
F2 The options were issued in connection with the reporting person's Board of Director service to the Company.